I. Demeester et al., VIVO INHIBITION OF DIPEPTIDYL PEPTIDASE-IV ACTIVITY BY PRO-PRO-DIPHENYL-PHOSPHONATE (PRODIPINE), Biochemical pharmacology, 54(1), 1997, pp. 173-179
Dipeptidyl peptidase IV (DPP IV, EC 3.4.14.5), also known as CD26, is
a membrane-bound serine protease that cleaves off aminoterminal dipept
ides from peptides with a penultimate proline (or, at a much slower ra
te, a penultimate alanine). Recently, we synthesized and characterized
a number of dipeptide-derived diphenylphosphonates. Out of the result
ing series of slow-binding irreversible inhibitors of DPP IV, diphenyl
1-(S)-prolylpyrrolidine-2(R,S)-phosphonate hydrochloride ( Pro-Pro-di
phenylphosphonate or Prodipine) was selected for further study. We inv
estigated the in vivo applicability of Prodipine. Male rabbits weighin
g 3-4 kg received a single intravenous injection with 10 mg Prodipine
or saline. After 1 hr, plasma DPP IV activity had decreased to less th
an 20% of the preinjection value and remained unchanged during a 24-hr
observation period. In a next step, we aimed to study (i) the dose de
pendency and (ii) the duration of the effect after a single intravenou
s dose of Prodipine. A. profound and long-lasting inhibition of plasma
DPP IV activity was observed in the treated animals (1, 5 or 10 mg).
It took 5 to 8 days to reach half of the pretreatment DPP IV activity
and generally more than 20 days for a complete recovery. Systemic trea
tment with Prodipine not only led to inhibition of plasma DPP IV activ
ity but also decreased tissue DPP IV activity in circulating mononucle
ar cells, kidney cortex, thymus, spleen, lung, and liver. No differenc
es in activities of the related peptidases aminopeptidase P (APP, EC 3
.4.11.9), prolyl oligopeptidase (PO, EC 3.4.21.26), or aminopeptidase
M (mAAP, EC 3.4.11.2) were detected between Prodipine-treated and cont
rol rabbits. The in vivo applicability of this chemically stable, irre
versible inhibitor of DPP IV opens new possibilities, not only to furt
her unravel the biological functions of this intriguing ectopeptidase,
but also to explore this enzyme as a new target in various fields of
pharmacological research. (C) 1997 Elsevier Science Inc.